http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08231415-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate | 1995-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587747325f78dc0dae417c281ae96303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71621d997abdeb50ec3f734567f50f00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1975d04c934d29aa3d5bde86449905d7 |
| publicationDate | 1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08231415-A |
| titleOfInvention | Drugs for diseases caused by abnormal platelet function |
| abstract | (57) [Summary] [Structure] Hepatocyte growth factor (eg 1) The molecular weight estimated by SDS-PAGE is about 76-92K; 2) it has the activity of growing hepatocytes; 3) 80 ° C, The activity is inactivated by heat treatment for 10 minutes; 4) The activity is inactivated by digestion with trypsin and chymotrypsin; 5) Prevention of diseases caused by dysfunction of platelets, which contains heparin with a strong affinity) as an active ingredient. Therapeutic drugs. [Effects] HGF, which is an active ingredient, has an action of increasing the number of platelets and improving dysfunction of platelets. Therefore, the drug of the present invention is effective in treating and / or preventing various diseases associated with thrombocytopenia. is there. |
| priorityDate | 1995-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.